Abstract
The clinical efficacy of non-steroidal, anti-inflammatory drugs (NSAIDs) is undisputed, as is their propensity to induce gastrointestinal mucosal lesions. Although several new substances and formulations have been developed during the past decades in the search for drugs with a more favourable side effect profile, the difference between the individual drugs remains small and is overshadowed by the interindividual variation in sensitivity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
